The effect of large dose intratumoral administration of OK-432 in advanced cancer patients.
D000818:Animals; D001688:Biological Products / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D008297:Male; D051379:Mice; D008937:Mitomycins / Q000008:administration & dosage; D010844:Picibanil / Q000008:administration & dosage*; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000276:immunology; D014374:Tuberculin Test
D001688:Biological Products; D008937:Mitomycins; D010844:Picibanil